Back to search

Article

Rifampicin and rifabutin resistance in 1000 <i>Mycobacterium tuberculosis</i> clinical isolates

2018-09-25

Abstract excerpt

<h4>Synopsis</h4> Drug resistant tuberculosis (TB) remains a public health challenge with limited treatment options and high associated mortality. Rifamycins are among the most potent anti-TB drugs, and the loss of susceptibility to these agents, a hallmark of MDR TB, is considered a substantial therapeutic challenge. Rifamycins are known to target the RpoB subunit of RNA polymerase; however, our understanding of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0a886ff6-a635-5527-823b-ff9be7d979b1
DOI
10.1101/425652
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Rifampicin and rifabutin resistance in 1000 <i>Mycobacterium tuberculosis</i> clinical isolatesDOI 10.1101/425652
Select a neighboring publication to make it the new centre.